Sutro Biopharma (STRO) Cash & Current Investments (2017 - 2026)
Sutro Biopharma (STRO) recorded Cash & Current Investments of $164.35 million in Q2 2026, down 19.9% from $205.13 million a year earlier.
Powered by 
Analysis
Sutro Biopharma (STRO) Cash & Current Investments (2017 - 2026) Analysis & Trends
At the end of FY2025, Sutro Biopharma reported Cash & Current Investments of $141.43 million, down 55.4% from FY2024.
- Annual Cash & Current Investments has a five-year compound annual growth rate of -15.4% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $316.9 million in FY2024 (-5.0%), $333.68 million in FY2023 (+10.4%), $302.34 million in FY2022 (+88.1%) and $160.76 million in FY2021 (-50.8%).
- Quarterly Cash & Current Investments has ranged from $141.43 million in Q4 2025 to $388.25 million in Q3 2024 over the past five years.
- On a year-over-year basis, Cash & Current Investments rose in 1 of the last seven quarters, with an average decline of 24.1%.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 88.1% in Q4 2022, against a decline of 56.8% in Q3 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | 505.00 Mn |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 14.27 Bn |
| 10 | Sutro Biopharma | 175.16 Mn | -500.76 Mn | - | 164.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 164.35 Mn |
| Dec 31, 2025 | 141.43 Mn |
| Sep 30, 2025 | 167.59 Mn |
| Jun 30, 2025 | 205.13 Mn |
| Mar 31, 2025 | 248.97 Mn |
| Dec 31, 2024 | 316.90 Mn |
| Sep 30, 2024 | 388.25 Mn |
| Jun 30, 2024 | 375.57 Mn |
| Mar 31, 2024 | 267.60 Mn |
| Dec 31, 2023 | 333.68 Mn |
| Sep 30, 2023 | 321.11 Mn |
| Jun 30, 2023 | 358.29 Mn |
| Mar 31, 2023 | 251.47 Mn |
| Dec 31, 2022 | 302.34 Mn |
| Sep 30, 2022 | 287.34 Mn |
| Jun 30, 2022 | 191.63 Mn |
| Mar 31, 2022 | 171.40 Mn |
| Dec 31, 2021 | 160.76 Mn |
| Sep 30, 2021 | 189.94 Mn |
| Jun 30, 2021 | 223.42 Mn |
API Access
Sutro Biopharma Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=STRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "STRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=STRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();